NSE: ALIVUS | BSE: 543322

Expensive Performer

Download real time

1206.00 25.10 (2.13%)

59.53% Gain from 52W Low

116.7K NSE+BSE Volume

NSE 15 May, 2025 3:31 PM (IST)

14,789.1

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Board Meeting

The board meeting for Alivus Life Sciences Ltd. is scheduled for today, for the purpose of Audited Results & Final Dividend See details

Alivus Life Sciences Ltd. News and Updates

Name: Latest research reports of Alivus Life Sciences Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Alivus Life Sciences Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Keep track of all breaking news on Alivus Life Sciences Ltd. from all sources in a single place.

Load latest

VOTE: Is Glenmark Life Sciences Ltd. worth buying?

122 Votes:

Buy 75.41%

Sell 13.11%

Hold 11.48%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Hold SEE REPORTS >

pdf